Amgros I/S (Amgros) is a partnership involving the five regions as stakeholders. Amgros aims to establish framework agreements for the pharmaceuticals listed in the individual subcontracts below, to supply the stakeholders' hospital pharmacies with medications, and potentially for resale to the Faro
Contract awarded. Originally published 6 months ago.
This contract opportunity is a re-tender of the previous sub-agreement for consulting services related to the ATMP Denmark program. The initial tender was canceled because the received bids did not meet the actual needs of Amgros. This tender involves awarding a framework agreement for consulting as
Amgros I/S is a partnership representing five regions in Denmark. They are seeking to establish framework agreements for the pharmaceuticals listed in the individual subcontracts below. The purpose is to supply the hospitals' pharmacies in these regions with medications, and potentially for resale t
Amgros I/S (Amgros) is a partnership with the five regions as stakeholders. Amgros aims to establish framework agreements for the pharmaceuticals listed in the individual subcontracts below, to supply the stakeholders' hospital pharmacies with medications and potentially for resale to the Faroe Isla
Amgros I/S is a partnership involving five regions in Denmark. They are seeking to establish framework agreements for the pharmaceuticals listed in the individual subcontracts below. The purpose is to supply the hospital pharmacies of the stakeholders with medications, and potentially for resale to
Supply non-clinical consumables including forms, labels, and packaging for pathology and primary care services.
Procurement of RSV immunisation vaccine products for adult populations, scheduled for 2028.
Procurement for meningococcal ACWY vaccine supply in 2027 from qualified manufacturers or distributors.
Procurement opportunity for MMR vaccine supply with anticipated delivery timeline of 2027.
